Holley (“Holley” or “the Company”), the largest and fastest growing platform for performance automotive enthusiasts, announced it has acquired substantially all of the assets...
Nanoscope Therapeutics Inc, a clinical-stage biotechnology company developing optogenetic gene therapies for retinal degenerative diseases, today announced that Nanoscope has been awarded U.S. patent...
BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, announced that it has entered into...
Hayward Holdings, Inc., global designer, manufacturer and marketer of a broad portfolio of pool equipment and technology, announced the acquisition of Water Works Technologies...
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,...
